REDMOND, Wash. - Oct. 13, 2011 - Microsoft Corp. and Quanta Computer Inc. have signed a patent agreement that provides broad coverage under Microsoft's patent portfolio for Quanta's tablets, smartphones and other consumer devices running the Android or Chrome Platform. Although the contents of the agreement have not been disclosed, the parties indicate that Microsoft will receive royalties from Quanta under the agreement.
"We are pleased to have reached this agreement with Quanta, and proud of the continued success of our Android licensing program in resolving IP issues surrounding Android and Chrome devices in the marketplace," said Horacio Gutierrez, corporate vice president and deputy general counsel, Intellectual Property Group at Microsoft.
Microsoft's Commitment to Licensing Intellectual Property
The patent agreement is another example of the important role IP plays in ensuring a healthy and vibrant IT ecosystem. Since Microsoft launched its IP licensing program in December 2003, the company has entered into more than 700 licensing agreements and continues to develop programs that make it possible for customers, partners and competitors to access its IP portfolio. The program was developed to open access to Microsoft's significant R&D investments and its growing, broad patent and IP portfolio.
More information about Microsoft's licensing programs is available at http://www.microsoft.com/iplicensing.
"We are pleased to have reached this agreement with Quanta, and proud of the continued success of our Android licensing program in resolving IP issues surrounding Android and Chrome devices in the marketplace," said Horacio Gutierrez, corporate vice president and deputy general counsel, Intellectual Property Group at Microsoft.
Microsoft's Commitment to Licensing Intellectual Property
The patent agreement is another example of the important role IP plays in ensuring a healthy and vibrant IT ecosystem. Since Microsoft launched its IP licensing program in December 2003, the company has entered into more than 700 licensing agreements and continues to develop programs that make it possible for customers, partners and competitors to access its IP portfolio. The program was developed to open access to Microsoft's significant R&D investments and its growing, broad patent and IP portfolio.
More information about Microsoft's licensing programs is available at http://www.microsoft.com/iplicensing.
全站熱搜
留言列表
生技醫療產業 (1)